Physician profile
Civia E Mccaffrey
NPI 1104935972
$2,323.36
in general payments reported to CMS, 2019-2025
12 companies · $481 in 2025
The $481 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $55.66 · 2021: $296 · 2022: $115 · 2023: $49.85 · 2024: $456 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $642.11 | 2019-2024 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $622.03 | 2019-2025 | Acuvue |
| Eyevance Pharmaceuticals LLC | $212.10 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $210.17 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $159.48 | 2024-2025 | Tryptyr, Total30 |
| Abb Con-Cise Optical Group LLC | $138.46 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $127.14 | 2021 | |
| Bausch & Lomb Americas INC. | $81.73 | 2023-2025 | Biotrue, Infuse, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $78.57 | 2020-2021 | |
| Oyster Point Pharma, INC. | $21.79 | 2023 | Tyrvaya |
| Dompe US, INC. | $18.74 | 2025 | Oxervate |
| Plexus Optix, INC. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Civia Mccaffrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.